Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04163198

Optimisation of Mechanical Insufflation:Exsufflation

Patients with neuromuscular diseases (NMD) can suffer from a range of respiratory problems due to respiratory muscle weakness. Cough muscle weakness means secretion clearance from the airways can be problematic, a source of infection, and importantly a cause of death, in this patient group. Therefore, these patients are often supported with devices to aid clearance, such as mechanical insufflation-exsufflation (MIE). Although evidence supports the use of these devices, the optimal technique or settings on the device are not clear. Increasingly, higher pressures are used during MIE and recent work has demonstrated that there may be a physiological benefit to this. However, higher pressures increase the risk of causing lung collapse and may cause detriment to blood flow back to the heart, which is important as NMD patients frequently have concurrent heart muscle weakness. Further, recent work has demonstrated that higher pressures can cause closure of the throat, which is counter-productive in secretion clearance.

The overall aim of this study is to investigate methods to manipulate MIE to improve secretion clearance in patients with NMD. The questions it seeks to answer are:

(i) how can we maximally improve lung recruitment during inspiration, whilst maintaining patient comfort and lower pressures (ii) what is the smallest pressure difference required in expiration to achieve an improvement in cough (iii) do these proposed changes to MIE also cause throat closure (iv) what factors do patients believe contribute to their adherence to MIE therapy?

Patients with slowly progressive or stable neuromuscular diseases will be included in the study. Participation will involve two visits to the Lane Fox Respiratory Unit, each lasting approximately four hours. Patients will be recruited from specialist neuromuscular respiratory clinics by their clinical teams.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Guys & St. Thomas' NHS Foundation Trust

London, SE1 7EH, United Kingdom

Location status: Recruiting

Location contact

Neeraj Shah, MBBS

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stable or slowly progressive neuromuscular disease
  • Respiratory muscle weakness (FVC <60%, snip <60%, sleep disordered breathing)
  • Clinical evidence of respiratory secretions or cough peak expiratory flow <270 and history of lower respiratory tract infection
  • Documented clinical stability by supervising clinician

Exclusion criteria

  • Rapidly progressive neuromuscular disease (such as motor neuron disease)
  • Decompensated respiratory failure (pH < 7.35)
  • Pregnancy
  • Aged <18
  • Change in ventilator settings in preceding 4 weeks
  • Significant physical or psychiatric co-morbidity that would prevent compliance with trial protocol

Treatment and study plan

Insufflation

Device

Patients will receive different inspiratory (Ti) and expiratory (Te) times and inspiratory flows, at a fixed insufflation and exsufflation pressure. Optimum insufflation pressure will be determined by measuring maximal inspiratory capacity.

Exsufflation

Device

Patients will receive different exsufflation pressures at fixed insufflation pressure.

Primary outcomes

  1. Cough peak expiratory flow (cPEF)

    Time frame: 2 days

    Change in cPEF with different modalities of MI-E

Study contacts

Contact information is provided by the study sponsor or research team.

Patrick Murphy, PhD

CONTACT

[email protected]

+442071888070

Sponsors and collaborators

Lead sponsor

Guy's and St Thomas' NHS Foundation Trust

Other

Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

Registry information

Official study title

Investigating Methods to Improve Secretion Clearance Using Mechanical Insufflation:Exsufflation in Patients With Neuromuscular Disease.

Acronym: MIE2

Important dates

Study start
2019
Primary completion
2027
Study completion
2027
First posted
Nov 14, 2019
Registry last updated
Jun 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.